Cargando…
Checkpoint inhibitor induced myositis – The value of MRI STIR
• Treatment with immune checkpoint inhibitors can cause serious adverse events. • Myositis combined with myocarditis ad adverse event have a mortality for 50%. • Early diagnosis is important for better outcome. • Employing MRI STIR can rapidly diagnose, guide biopsy, and classify cases of immune-rel...
Autores principales: | Erritzøe-Jervild, Mai, Scheie, David, Stenør, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849862/ https://www.ncbi.nlm.nih.gov/pubmed/36683900 http://dx.doi.org/10.1016/j.ensci.2022.100442 |
Ejemplares similares
-
A case report of immune checkpoint inhibitor-related steroid-refractory myocarditis and myasthenia gravis-like myositis treated with abatacept and mycophenolate mofetil
por: Jespersen, Mette Syberg, et al.
Publicado: (2021) -
Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor‐related myocarditis and myositis: rechallenge?
por: Rossi, Valentina A., et al.
Publicado: (2023) -
Tropomyosin autoantibodies associated with checkpoint inhibitor myositis
por: Zaenker, Pauline, et al.
Publicado: (2020) -
Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor
por: Ünlütürk, Zeynep, et al.
Publicado: (2023) -
Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma
por: Liu, Yuan, et al.
Publicado: (2019)